Literature DB >> 15900594

Maternal height, pregnancy estriol and birth weight in reference to breast cancer risk in Boston and Shanghai.

Pagona Lagiou1, Evi Samoli, Areti Lagiou, Chung-Cheng Hsieh, Hans-Olov Adami, Dimitrios Trichopoulos.   

Abstract

Birth weight has been positively associated with breast cancer risk in adult life and is positively associated with the principal pregnancy estrogen estriol. Birth weight is lower among Chinese women than among Caucasian women, but paradoxically, pregnancy estriol levels are higher among the former than the latter. We studied a cohort of 317 Caucasian pregnant women in Boston, MA, and 339 Chinese pregnant women in Shanghai, China. We investigated whether maternal height, which is inversely associated with pregnancy estriol levels, interacts with this hormone in relation to birth weight, thus accommodating the apparently contradictory ecologic and analytic evidence concerning the role of pregnancy estrogens on breast cancer risk in the offspring. In both Boston and Shanghai, there was a positive association of pregnancy estriol with birth weight among taller women, whereas among shorter women the association was essentially null. The relevant interaction terms were highly significant in Boston (p approximately 0.006), whereas in Shanghai, where pregnant women were generally shorter, the interaction term was suggestive (p approximately 0.14). We conclude that maternal height should be considered an important risk factor for breast cancer in the offspring since it is a crucial determinant of birth weight, both directly and through positive interaction with the principal pregnancy estrogen estriol. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900594     DOI: 10.1002/ijc.21198

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Conditions in utero and cancer risk.

Authors:  Tom Grotmol; Elisabete Weiderpass; Steinar Tretli
Journal:  Eur J Epidemiol       Date:  2006-09-13       Impact factor: 8.082

2.  Size at birth and risk of breast cancer: update from a prospective population-based study.

Authors:  Marie Søfteland Sandvei; Pagona Lagiou; Pål Richard Romundstad; Dimitrios Trichopoulos; Lars Johan Vatten
Journal:  Eur J Epidemiol       Date:  2015-05-31       Impact factor: 8.082

3.  Maternal and cord blood hormones in relation to birth size.

Authors:  Pagona Lagiou; Evangelia Samoli; Chung-Cheng Hsieh; Areti Lagiou; Bio Xu; Guo-Pei Yu; Sagano Onoyama; Lucy Chie; Hans-Olov Adami; Lars J Vatten; Dimitrios Trichopoulos; Michelle A Williams
Journal:  Eur J Epidemiol       Date:  2014-05-22       Impact factor: 8.082

4.  Energy intake during pregnancy in relation to offspring gender by maternal height.

Authors:  Pagona Lagiou; Evangelia Samoli; Loren Lipworth; Areti Lagiou; Fang Fang; Marta Rossi; Biao Xu; Guo-Pei Yu; Hans-Olov Adami; Chung-Cheng Hsieh; Dimitrios Trichopoulos
Journal:  Eur J Epidemiol       Date:  2010-11-30       Impact factor: 8.082

5.  Mothers' pre-pregnancy BMI and weight gain during pregnancy and risk of breast cancer in daughters.

Authors:  Kathryn M Wilson; Walter C Willett; Karin B Michels
Journal:  Breast Cancer Res Treat       Date:  2011-05-20       Impact factor: 4.872

6.  Biological indicators of the in-utero environment and their association with birth weight for gestational age.

Authors:  N M Talge; C Holzman; P K Senagore; M Klebanoff; R Fisher
Journal:  J Dev Orig Health Dis       Date:  2011-10       Impact factor: 2.401

7.  Non-linear and gender-specific relationships among placental growth measures and the fetoplacental weight ratio.

Authors:  D P Misra; C M Salafia; R K Miller; A K Charles
Journal:  Placenta       Date:  2009-10-29       Impact factor: 3.481

8.  Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk.

Authors:  P Lagiou; C C Hsieh; L Lipworth; E Samoli; W Okulicz; R Troisi; B Xu; P Hall; A Ekbom; H O Adami; D Trichopoulos
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.